Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
November 18, 2016 Curriculum Vitae Ihor Gussak, MD, PhD, FACC IHOR GUSSAK, MD, PhD, FACC Citizenship: Marital Status: Address: e-mail: U.S. Citizen Wife: Hiie M. Gussak, MD, BC/BE Nephrologist Morristown, NJ [email protected] Employment and Academic Appointments 2014 – present Full-time Cardiology Consultant (Pharmaceuticals and Device), Ihor Gussak Consulting LLC Early Stages Clinical Research & Drugs Development o o o Acute and Chronic Heart Failure Programs o Design and Implementation of Clinical Development Programs. CDP, FIH, FIP, POP, and POC studies o Interactions with KoLs, CROs, Regulatory Authorities. IB, IND, NDA Acute Coronary Syndrome and Myocardial Infarction o o o Cardiac Telemetry Cardiac Diagnostic Technologies Clinical Electrocardiography and Cardiac Electrophysiology o o 2004 – present 2012 – 2014 ECG Interpretation and Serial ECGs Comparison Holter Analysis and Exercise Tests Interpretation Ischemic Event Adjudication and Classification Medical Device Industry o o 2006 – present Cardiac Safety Pharmacology and Medical Monitoring of Cardiac and Non-cardiac Investigational Drugs Pre-clinical Research, Translational Medicine, and Clinical Trials Licensing Opportunities Hereditary and Acquired Cardiac Channelopathies. Long and Short QT Syndromes, Brugada Syndrome Molecular, Ionic, and Genetic Aspects of Hereditary Electrical Diseases of the Heart Iatrogenic Cardiovascular Medicine Various Biotechnology Companies, CROs, and Advisory Boards Clinical Professor of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ Executive Editor, Journal of Electrocardiology Full-time Consultant, ONO Pharmaceutical Lawrenceville, NJ and London, UK. Main responsibilities: Heart Failure Program and Cardiac Safety FIH, PoP, IB, IND, Interactions with FDA Establishing key opinion leaders panel for heart failure program 2012 – 2012 Director, Cardiac Safety Pharmacology, Masonic Medical Research Laboratory Utica, NY 2008 – 2012 Vice President and Chief Medical Officer, NewCardio, Inc Princeton, NJ and Santa Clara, CA Deputy Therapeutic Area Head, Cardiovascular, Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT. Main responsibilities: 2007 – 2008 2002 – 2007 Molecular, Ionic, and Genetic Aspects of Hereditary Electrical Diseases of the Heart In-licensing of cardiovascular products (identifying new clinical research opportunities) Clinical/scientific support for internal cardiovascular clinical and pre-clinical R&D Assessment of cardiac safety of non-cardiac drugs Establishing panels of key opinion leaders for various cardiovascular indications, scientific presentations at advisory boards, key scientific meetings and external committee meetings Vice President, Global Medical Affairs, eResearchTechnology, Inc Bridgewater, NJ. Main responsibilities: Cardiac safety evaluations of investigational drugs Interactions with key sponsors and regulatory agencies 1 November 18, 2016 2001 – 2002 1999 – 2001 1999 – 2001 1996 – 1999 1997 – 1999 1992 – 1996 1991 – 1992 1981 – 1991 1986 – 1991 1986 – 1989 1980 – 1981 Ihor Gussak, MD, PhD, FACC Associate Global Director, Cardiovascular Clinical R&D, Aventis Pharmaceuticals, Bridgewater, NJ. Main responsibilities: 2000 – 2001 Curriculum Vitae Execution of the early phases clinical trials in anti-hypertensive program Participation in safety assessment Interactions with regulatory agencies, IND support Establishing key opinion leaders panel for anti-hypertensive program Director, Mayo ECG Core Laboratory within Mayo Clinical Trial Services (MPACT) Mayo Clinic Rochester, MN Professional Research Associate, Mayo Physician Alliance for Clinical Trials (MPACT) Mayo Clinic, Rochester, MN Cardiology Consultant (adjunct position), Biomedical Systems, St. Louis, MO Assistant Professor, Department of Cardiology St. Louis University Health Sciences Center, St. Louis, MO Lecturer (adjunct position), Department of Pharmacological and Physiological Sciences St. Louis University School of Medicine, St. Louis, MO Postdoctoral Cardiology Research Fellow St. Louis University, St. Louis, MO ECG analyst, St. Joseph Hospital, Cheektowaga, NY Attending Physician, Department of Cardiology / Intensive and Coronary Care Units Tartu University Hospital, Tartu, Estonia Senior Scientist, Laboratory of Clinical Physiology (adjunct position) Tartu University School of Medicine, Tartu, Estonia Instructor in Cardiology (adjunct position) Department of Continuing Education, Tartu University School of Medicine, Tartu, Estonia Intern, Department of Internal Medicine and Cardiology, Tartu University, Estonia Education 1992 – 1996 PhD (1983-86) MD (1974-80) Postdoctoral Cardiology Research Fellowship St. Louis University Health Sciences Center, St. Louis, MO Cardiac Electrophysiology of Acute Myocardial Ischemia in Clinic and Experiments Conducted: National Center for Surgical Treatment of Severe Cardiac Rhythm Disturbance and Cardiac Pacing (Kaunas, Lithuania) and Tartu University (Tartu, Estonia) Defended: Institute of Continuing Medical Education, St. Petersburg, Russia Tartu University School of Medicine, Tartu, Estonia Certificates 2002 2001 1988 1985 1981 1980 Certificate of Tufts Center for the Study of Drug Development, Tufts University, Boston, MA USA Certificate of American College of Cardiology, Bethesda, MD USA Certificate of Surgical Treatment of Severe Cardiac Rhythm Disorders and Permanent Cardiac Pacing Kaunas University School of Medicine, Kaunas, Lithuania Certificate of General Methods of Electrophysiological Diagnosis and Temporary Cardiac Pacing Kaunas University School of Medicine, Kaunas, Lithuania Certificate of Internship in Internal Medicine, Tartu University Clinical Hospital, Tartu, Estonia Certificate of Sport Medicine, Tartu University, Tartu, Estonia Awards (USA Only) “America's Top Cardiologists” by Consumer's’ Research Council of America Certificate of Appreciation by the Asymptomatic Cardiac Ischemia Pilot Study (ACIP) A research project of the National Heart, Lung, and Blood Institute, 1995 Certificate of Appreciation by the Physiological Investigations of Myocardial Ischemia (PIMI) A research project of the National Heart, Lung, and Blood Institute, 1993-1995 2 November 18, 2016 Curriculum Vitae Ihor Gussak, MD, PhD, FACC Scientific Interests Clinical Research and Drug Development o Clinical Trials and Cardiac Safety o Acute and Chronic Heart Failure Clinical Electrocardiography and Cardiac Electrophysiology o Electrical Diseases of the Heart and Sudden Cardiac Death o Short and Long QT Syndromes, Brugada Syndrome, Primary Idiopathic Cardiac Asystole o Acute Coronary Syndrome and Myocardial Infarction Iatrogenicity in Cardiovascular Medicine American College of Cardiology, Fellow American Heart Association, Clinical Cardiology Council American Academy of Pharmaceutical Physicians International Cardiac Electrophysiology Society International Society for Holter and Noninvasive Electrocardiology Drug Information Association Mayo Medical Alumni Association, Mayo Foundation International Scientific Committee on Arrhythmogenic Right Ventricular Dysplasia-Cardiomyopathy Ukrainian Society of Cardiology, Fellow Ukrainian Cardiology Journal, Member of Editorial Board Cardiac Surgery and Interventional Cardiology, Member of Editorial Board Strazhesko Institute of Cardiology, Kyiv, Ukraine, Honorary Professor Ukrainian Shevchenko Scientific Society, Full Member Memberships Ad hoc Reviewer: Journal of the American College of Cardiology, Circulation, American Journal of Cardiology, Pacing and Clinical Electrophysiology, Clinical Cardiology, Nature Teaching Activities 2006 – 2010 1999 1997 -1998 1986 -1989 Lectures and Seminars on Clinical Electrocardiology UMDNJ-RWJ Medical School, New Brunswick, NJ Course of “Clinical Cardiology” University of Health Sciences Antigua School of Medicine (On-line), St. John’s, Antigua, WI Lectures and Seminars on Cardiac Electrophysiology and Electrocardiology Department of Pharmacological and Physiological Sciences St. Louis University School of Medicine, St. Louis, MO Lectures and Seminars on Clinical Cardiology, Clinical Electrophysiology and Electrocardiology Department of Continuing Medical Education, Tartu School of Medicine, Tartu, Estonia Numerous lectures and presentations at national and international congresses, seminars, and conferences 3 November 18, 2016 Curriculum Vitae Ihor Gussak, MD, PhD, FACC SELECTED BIBLIOGRAPHY (only books, books chapters, and manuscripts) Textbooks: 1. IATROGENICITY IN CARDIOVASCULAR MEDICINE (First Edition, in progress) Editors: Ihor B. Gussak and John B. Kostis Co-Editors: Arshad Jahangir, Gan-XinYan, Giovanni Campanile, William J. Kostis, Ibrahim Akin, and Martin Borggrefe Rutgers University Press, New Brunswick, NJ, USA, 2017 2. ELECTRICAL DISEASES OF THE HEART (Second Edition) Volume 1. Basic Foundations and Primary Electrical Diseases. Pp. 695 Volume 2. Clinical Rhythmology: Diagnosis and Treatment of Electrical Diseases of the Heart, and Prevention of Sudden Cardiac Death. Pp.743 Editors: Ihor Gussak and Charles Antzelevitch Co-editors: Arthur Wilde, Brian Powell, Michael Ackerman, and Win-Kuang Shen Springer, 2 volumes, 2013 3. ELECTRICAL DISEASES OF THE HEART: Genetics, Mechanisms, Treatment, Prevention Editors: Ihor Gussak and Charles Antzelevitch Co-editors: Arthur Wilde, Paul Friedman, Michael Ackerman, and Win-Kuang Shen Springer, 1000 pp, 2008 4. CARDIAC SAFETY OF NONCARDIAC DRUGS: PRACTICAL GUIDELINES FOR CLINICAL RESEARCH AND DRUG DEVELOPMENT Edited by J. Morganroth and I. Gussak. Humana, 361 pp, 2004 5. CARDIAC REPOLARIZATION: BRIDGING BASIC AND CLINICAL SCIENCE Edited by Gussak I, Antzelevitch C, Hammil SC, Shen W-K, Bjerregaard P. Humana, 548 pp, 2003 6. CLINICAL MANAGEMENT OF CARDIAC ARRHYTHMIAS Gussak I, Gussak H, Teesalu R. Tartu University, Tartu, 1989 7. ATLAS OF COMBINED CARDIAC RHYTHM DISORDERS Gussak I. Tartu University, Tartu, 1984 4 November 18, 2016 Curriculum Vitae Ihor Gussak, MD, PhD, FACC Books Chapters: 1. Gussak I, Jahangir A, Gan-XinYan G-X, Kostis K. Clinical Manifestations of Acute and Chronic Drug-Induced Iatrogenic Cardiovascular Diseases and Syndromes. Chapter 7. In: IATROGENICITY IN CARDIOVASCULAR MEDICINE (First Edition, in progress) Editors: Ihor B. Gussak and John B. Kostis. Co-editors: Arshad Jahangir, Gan-XinYan, Giovanni Campanile, William J. Kostis, Ibrahim Akin, and Martin Borggrefe. Rutgers University Press, First Edition, 2017 (in progress) 2. Maria L. Gussak, Ihor B. Gussak, and John B. Iatrogenicity: Definition, History and Modern Context. In: IATROGENICITY IN CARDIOVASCULAR MEDICINE (First Edition, in progress) Editors: Ihor B. Gussak and John B. Kostis. Co-editors: Arshad Jahangir, Gan-XinYan, Giovanni Campanile, William J. Kostis, Ibrahim Akin, and Martin Borggrefe. Rutgers University Press, First Edition, 2017 (in progress) 3. Sulaiman Sultan, Ahad Jahangir, Ihor B Gussak, John B Kostis, A Jamil Tajik, Arshad Jahangir. Interactions between supplements and prescription medications. In: IATROGENICITY IN CARDIOVASCULAR MEDICINE (First Edition, in progress) Editors: Ihor B. Gussak and John B. Kostis. Co-editors: Arshad Jahangir, Gan-XinYan, Giovanni Campanile, William J. Kostis, Ibrahim Akin, and Martin Borggrefe. Rutgers University Press, First Edition, 2017 (in progress) 4. Safety of Over-the-counter “Natural Substances” and “Vitamins”: Side Effects, and Contraindications. Sulaiman Sultan, Ahad Jahangir, Ihor B Gussak, A Jamil Tajik, Arshad Jahangir. In: IATROGENICITY IN CARDIOVASCULAR MEDICINE (First Edition, in progress) Editors: Ihor B. Gussak and John B. Kostis. Co-editors: Arshad Jahangir, Gan-XinYan, Giovanni Campanile, William J. Kostis, Ibrahim Akin, and Martin Borggrefe. Rutgers University Press, First Edition, 2017 (in progress) 5. Gussak I and Gussak G. History of the J Wave and J Wave Syndromes. In: J Wave Syndrome. Edited by Antzelevitch C. and Yan G-X. Springer International Publishing Switzerland, 2016 6. Rashmi R Shah RR and Gussak I. Acquired (Drug-Induced) Long and Short QT Syndromes. Chapter 6. Pp. 73122. In: ELECTRICAL DISEASES OF THE HEART (Second Edition) Volume 2. Clinical Rhythmology: Diagnosis and Treatment of Electrical Diseases of the Heart, and Prevention of Sudden Cardiac Death. Editors: Ihor Gussak and Charles Antzelevitch Co-editors: Arthur Wilde, Brian Powell, Michael Ackerman, and Win-Kuang Shen Springer, 2013 7. Passman R, Ots M, Gussak I, Gussak, H. Sudden Cardiac Arrest in Chronic Kidney Disease. Chapter 30. Pp. 475-486. In: ELECTRICAL DISEASES OF THE HEART (Second Edition) Volume 2. Clinical Rhythmology: Diagnosis and Treatment of Electrical Diseases of the Heart, and Prevention of Sudden Cardiac Death. Editors: Ihor Gussak and Charles Antzelevitch Co-editors: Arthur Wilde, Brian Powell, Michael Ackerman, and Win-Kuang Shen Springer, 2013 5 November 18, 2016 Curriculum Vitae Ihor Gussak, MD, PhD, FACC 8. Gussak HM, Ots M, and Gussak I. Sudden Death in Kidney Diseases. Chapter 63. Pp. 934-942 In: ELECTRICAL DISEASES OF THE HEART AND SUDDEN CARDIAC DEATH. Edited by Gussak I. Antzelevitch C, Wilde A, Friedman P, Ackerman MJ, Shen WK. Springer, 1000 pp, November 2008 9. Bjerregaard P, Gussak I. Short QT Syndrome. In: ELECTRICAL DISEASES OF THE HEART AND SUDDEN CARDIAC DEATH. Edited by Gussak I. Antzelevitch C, Wilde A, Friedman P, Ackerman MJ, Shen WK. Springer, 1000 pp, November 2008 10. Litwin J, Kleiman R, and Gussak I. Acquired (Drug-Induced) Long QT Syndrome. Chapter 46, Pp. 705-718. In: ELECTRICAL DISEASES OF THE HEART AND SUDDEN CARDIAC DEATH. Edited by Gussak I. Antzelevitch C, Wilde A, Friedman P, Ackerman MJ, Shen WK. Springer, 1000 pp, November 2008 11. Gussak I, Kleiman R, Litwin J. Fundamentals of ECG Interpretation in Clinical Research. In: CARDIAC SAFETY OF NONCARDIAC DRUGS: PRACTICAL GUIDELINES FOR CLINICAL RESEARCH AND DRUG DEVELOPMENT. Edited by J. Morganroth and I. Gussak. 361 pages. Humana, 2004 12. Gussak I. A History of the Brugada Syndrome or A Decade of Success. In: Brugada Syndrome. Blackwell Publishing, 2005 13. Gussak I, Antzelevitch C, Bjerregaard P. ECG Phenomena of the Early Ventricular Repolarization. Early Repolarization Syndrome. Pp 407-426. In: Gussak I, Antzelevitch C, Hammil SC, Shen W-K, Bjerregaard P. Cardiac Repolarization: Bridging Basic and Clinical Science. Humana, 2003 14. Gussak I, Bjerregaard P, Goodman D, Antzelevitch C. Short QT interval: ECG Phenomenon and Clinical Syndrome. Pp. 497-506. Chapter 18. In: Gussak I, Antzelevitch C, Hammil SC, Shen W-K, Bjerregaard P. Cardiac Repolarization: Bridging Basic and Clinical Science. Humana, 2003 15. Gussak I, Chaitman BR. The Brugada Syndrome. Chapter 58. In: Harrison’s Advances in Cardiology. Pp. 370-377, Edited by E. Braunwald. McGraw-Hill, 2002 16. Gussak I, Chaitman BR. The Brugada Syndrome. Chapter 231 In: Harrison’s Principles of Internal Medicine. McGraw Hill, 1999 http://www.harrisonsonline.com/server-java/Arknoid/amed/harrisons/ex_editorials/edl1915_p01.html 17. Gussak I. Cardiac Electrophysiology. Pp.6.1-6.18. Human Organ System. Cardiovascular Module. Saint Louis University. School of Medicine. St. Louis, MO, 1998 18. Gussak I. Abnormal ECG and Cardiac Arrhythmias. Pp.11.1-11.14. Human Organ System. Cardiovascular Module. Saint Louis University. School of Medicine. St. Louis, MO, 1998 19. Gussak I. Clinical Cardiology University of Health Sciences Antigua School of Medicine, St. John's, Antigua, WI, www.uhsa.ag (online courses) 6 November 18, 2016 Curriculum Vitae Ihor Gussak, MD, PhD, FACC Manuscripts: 1. Clinical Significance of J waves in Patients Undergoing Therapeutic Hypothermia for Out-of-Hospital Cardiac 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. Arrest. Harhash A, Gussak I, Cassuto J, Winters SL. PACE-16-0327.R2 (in press) Antzelevitch C, Yan GX, Ackerman MJ, Borggrefe M, Corrado D, Guo J, Gussak I, Hasdemir C, Horie M, Huikuri H, Ma C, Morita H, Nam GB, Sacher F, Shimizu W, Viskin S, Wilde AA. J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge. J Arrhythm. 2016 Oct;32(5):315-339. Antzelevitch C, Yan G-X, Ackerman MJ, Borggrefe M, Corrado D, Guo J, Gussak I, Hasdemir C, Horie M, Huikuri H, Ma C, Morita H, Nam G-B, Sacher F, Shimizu W, Viskin S, Wilde AAM. J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge. Endorsed by: the Asia Pacific Heart Rhythm Society (APHRS), the European Heart Rhythm Association (EHRA), the Heart Rhythm Society (HRS), and the Latin American Society of Cardiac Pacing and Electrophysiology (Sociedad Latinoamericana de Estimulacifin Cardíaca y Electrofisiología [SOLAECE]). Heart Rhythm. 2016 Jul 11. pii: S1547-5271(16)30372-1. doi: 10.1016/j.hrthm.2016.05.024 Antzelevitch C, Yan G-X, Ackerman MJ, Borggrefe M, Corrado D, Guo J, Gussak I, Hasdemir C, Horie M, Huikuri H, Ma C, Morita H, Nam G-B, Sacher F, Shimizu W, Viskin S, Wilde AAM. J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge. Endorsed by: the Asia Pacific Heart Rhythm Society (APHRS), the European Heart Rhythm Association (EHRA), the Heart Rhythm Society (HRS), and the Latin American Society of Cardiac Pacing and Electrophysiology (Sociedad Latinoamericana de Estimulacifin Cardíaca y Electrofisiología [SOLAECE]). Europace. 2016 Jul 13. pii: euw235 Ward CL, Jamieson V, Nabata T, Sharpe, Dozono K, Suto F, Hashimoto Y, Gussak I. First Clinical Experience with ONO-4232: A Randomized, Double-Blind, Placebo-Controlled Healthy Volunteer Study of a Novel Lusitropic Agent for Acutely Decompensated Heart Failure. Clinical Therapeutics/ 2016 Mar 18. pii: S0149-2918(16)30088-1. doi Brugada J1, Gussak I, Brugada P. Short QT Syndrome: A Predictable Story. Cardiology. 2014 May 6;128(3):231-233 Gussak I and Antzelevitch C. Early Repolarization Syndrome: A Decade of Progress. Editorial J of Electrocardiology, 2013,Mar;46(2):110-3 Antzelevitch C, Gussak I. Author's response to Letter to the Editor from Perez and Froelicher. J Electrocardiol. 2013 Mar;46(2):116 Detection of QT prolongation using a novel automated ECG analysis algorithm: Prospective blinded evaluation using the Cardiac Safety Research Consortium ECG database. Cynthia L. Green, Paul Kligfield, Samuel George, Ihor Gussak, Branislav Vajdic, Philip Sager, MD, Mitchell W. Krucoff, MD. Am Heart J. 2012 Mar;163(3):365-71 Vukajlovic D, Gussak I, George S, Simic G, Bojovic B, Hadzievski L, Stojanovic B, Angelkov L, Panescu D. Wireless monitoring of reconstructed 12-lead ECG in atrial fibrillation patients enables differential diagnosis of recurrent arrhythmias. Conf Proc IEEE Eng Med Biol Soc. 2011 Aug;2011:4741-4 Wenzel BJ, George S, Lakkireddy D, Vanga S, Bommana S, Gussak I, Simic G, Bojovic B, Hadzievski L, Panescu D. Algorithm for quantitative 3 dimensional analysis of ECG signals improves myocardial diagnosis over cardiologists in diabetic patients. Conf Proc IEEE Eng Med Biol Soc. 2011 Aug;2011:965-8 Gussak I, Vukajlovic D, Vukcevic V, George S, Bojovic B, Hadzievski L, Simic G, Stojanovic B, Angelkov L, Panescu D. Wireless remote monitoring of reconstructed 12-lead ECGs after ablation for atrial fibrillation using a hand-held device. J Electrocardiol. 2011 Nov 9. [Epub ahead of print] Vukajlovic D, Bojovic B, Hadzievski L, George S, Gussak I, Panescu D. Wireless remote monitoring of atrial fibrillation using reconstructed 12-lead ECGs. Conf Proc IEEE Eng Med Biol Soc. 2010;2010:1113-8 7 November 18, 2016 Curriculum Vitae Ihor Gussak, MD, PhD, FACC 14. Vukcevic V, Panescu D, Bojovic B, George S, Gussak I, Giga V, Stankovic I. Wireless remote monitoring of myocardial ischemia using reconstructed 12-lead ECGs. Conf Proc IEEE Eng Med Biol Soc. 2010;2010:2215-20 15. Akshay Dhawan, Brian Wenzel, Samuel George, Ihor Gussak, Bosko Bojovic, Dorin Panescu. DETECTION OF ACUTE MYOCARDIAL INFARCTION FROM SERIAL ECG USING MULTILAYER SUPPORT VECTOR MACHINE. Conf Proc IEEE Eng Med Biol Soc. 2011 (in press) 16. George, S; Rodriguez, I; Ipe, D; Sager, P; Gussak, I; Vajdic, B. Computerized Extraction of Electrocardiograms from Continuous 12-Lead Holter Recordings Reduces Measurement Variability in a Thorough QT Study. J Clin Pharmacol. 2012 Dec;52(12):1891-900. doi: 10.1177/0091270011430505. Epub 2011 Dec 20. 17. Ihor Gussak, Dejan Vukajlovic, Vladan Vukcevic, Samuel George, Bosko Bojovic, Ljupco Hadzievski, Goran Simic, 1 Bojan Stojanovic, Lazar Angelkov, Dorin Panescu. Wireless Remote Monitoring of Reconstructed 12Lead ECGs After Ablation for Atrial Fibrillation Using a Hand-Held Device. J of Electrocardiol (in press) 18. Shah RR, Bjerregaard P, Gussak I. Drug-induced QT interval shortening: an emerging component in integrated assessment of cardiac safety of drugs. J Electrocardiol. 2010 Sep-Oct;43(5):386-9 19. Bjerregaard P, Nallapaneni H, Gussak I. Short QT interval in clinical practice. J Electrocardiol. 2010 Sep-Oct;43(5):390-5 20. Shvilkin A, Bojovic B, Vajdic B, Gussak I, Ho KK, Zimetbaum P, Josephson ME. Vectorcardiographic and electrocardiographic criteria to distinguish new and old left bundle branch block. Heart Rhythm. 2010 Aug;7(8):1085-92 21. Bojovic B, Hadzievski L, Vukcevic VD, Panescu D, Gussak I, George S, Shvilkin A, Vajdic B. Visual 3Dx: algorithms for quantitative 3-dimensional analysis of ECG signals. Conf Proc IEEE Eng Med Biol Soc. 2009;2009:6751-4 22. Corrado D, Pelliccia A, Heidbuchel H, Sharma S, Link M, Basso C, Biffi A, Buja G, Delise P, Gussak I et al; on behalf of the Sections of Sports Cardiology of the European Association of Cardiovascular Prevention and Rehabilitation; and the Working Group of Myocardial and Pericardial Disease of the European Society of Cardiology. Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J. 2010 31(2):243-259 23. Bojovic B, Hadzievski L, Vukcevic VD, Panescu D, Gussak I, George S, Shvilkin A, Vajdic B. Visual 3Dx: Algorithms for quantitative 3-dimensional analysis of ECG signals. Conf Proc IEEE Eng Med Biol Soc. 2009;1:6751-4. 24. Shvilkin A, Bojovic B, Vajdic B, Gussak I, Zimetbaum P, Josephson ME. Vectorcardiographic determinants of cardiac memory during normal ventricular activation and continuous ventricular pacing. Heart Rhythm. 2009 Jul;6(7):943-8. Epub 2009 Mar 19. 25. I. Gussak, S. George, B. Bojovic, B. Vajdic. ECG Phenomena of the Early Ventricular Repolarization in the 21 Century. Indian Pacing Electrophysiol J. 2008 Jul–Sep; 8(3). Published online 2008 July 1 26. C. Wolpert, C. Antzelevitch, C. Veltmann, R.Schimpf, I.Gussak, M. Borggrefe. Is a "Narrow and Tall" QRS Complex an ECG Marker for Sudden Death? Heart Rhythm Journal, 2008 (in press) 27. I. Gussak, P. Bjerregaard. Electrical Storm in Acute Myocardial Infarction. Polish Heart Journal, September 2008 28. Gussak I, Gussak H. Sudden cardiac death in nephrology: focus on acquired long QT syndrome. Editorial Comments. Nephrology Dialysis Transplantation 2006; doi: 10.1093/ndt/gfl587 29. Gussak I. Molecular pathogenesis of catecholaminergic polymorphic ventricular tachycardia: Sex matters! Heart Rhythm. 2006 Jul;3(7):806-7. 30. Bjerregaard P, Jahangir A, Gussak I. Targeted therapy for short QT syndrome. Expert Opin Ther Targets. 2006 Jun;10(3):393-400. 8 November 18, 2016 Curriculum Vitae Ihor Gussak, MD, PhD, FACC 31. Bjerregaard P, Gussak I. Short QT Syndrome. Ann Noninvasive Electrocardiol. 2005 Oct;10(4):436-40. 32. Gussak I, Bjerregaard P. Short QT syndrome-5 years of progress. J Electrocardiol. 2005 Oct;38(4):375-7. 33. Hong K, Bjerregaard P, Gussak I, Brugada R. Short QT syndrome and atrial fibrillation caused by mutation in KCNH2. J Cardiovasc Electrophysiol, v.16, 99.394-6, 2005 34. Bjerregaard P, Gussak I. Short QT syndrome: mechanisms, diagnosis and treatment. Nature. Clinical Practice Cardiovascular Medicine (2005) 2, 84-87 35. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, Lemarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H, Wilde A. Brugada Syndrome. Report of the Second Consensus Conference. Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation. 2005 Feb 8;111(5):659-70. Epub 2005 Jan 17 36. Gussak I, Bjerregaard P, Kostis J. Electrocardiographic “Lambda” wave and primary idiopathic cardiac asystole: A new clinical syndrome? J Electrocardiol April 2004 • Volume 37 • Number 2 37. Gussak I, Litwin J, Kleiman R, Grisanti S, Joel Morganroth J. Drug-Induced Cardiac Toxicity: Emphasizing the Role of Electrocardiography In Clinical Research and Drug Development. Editorial Review. J of Electrocardiol 2004: 37 (1): 19-24 38. Antzelevitch C., Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Riera ARP, Tan H, Shimizu W, Wilde A. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation. 2005 Feb 8;111(5):659-70 39. Murphy J, Wright RS, Gussak I, Williams B, Daly RN, Cain VA, Pieniaszek HJ, Sy SKB, Ebling W, Simonson K, Wilcox R, Kopecky SL. The use of roxifiban (DMP754), a novel oral platelet glycoprotein IIb/IIIa receptor inhibitor, in patients with stable coronary artery disease. Am J Cardiovasc Drugs 2003: 3 (2): 101-112 40. Gussak I, Startt Selvester RH. Editorial announcement. J Electrocardiol 2004 Oct;36(2):87 41. Gussak I, Startt Selvester RH. Editorial announcement. J Electrocardiol 2002 Oct;35(4):287 42. Antzelevitch C, Brugada P, Brugada J, Brugada R, Shimizu W, Gussak I, Riera ARP. Brugada Syndrome. A Decade of Progress. A Historical Perspective. Circulation Research 2002;91:1114-1118 43. Gussak I, Brugada P, Brugada J, Antzelevitch, Osbakken M, Bjerregaard P. ECG Phenomenon of Idiopathic Short QT Interval. Cardiac Electrophysiology Review 6:49-53, 2002 44. Gussak I, Bjerregaard P, Hammill SC. Clinical Diagnosis and Risk Stratification in Patients with Brugada Syndrome. Editorial Comments. Journal of the American College of Cardiology 37, No. 6,1635-8, 2001 45. Bjerregaard P, Gussak I. Brugada Syndrome – 10 Years Later. J Electrocardiol 35 (1): 85-87, 2002 46. Gussak I, Brugada P, Brugada J, Wright RS, Kopecky SL, Chaitman BR, Bjerregaard P. Idiopathic Short QT Interval: A New Clinical Syndrome? Cardiology 94 (2), 99-102, 2000 47. Gussak I, Wright, RS, Bjerregaard P, Chaitman BR, Zhou SH, Hammill SC, Kopecky SL. False-Negative and False-Positive ECG Diagnoses of Q Wave Myocardial Infarction in the Presence of Right Bundle-Branch Block. Cardiology 94 (3), 165-172, 2000 48. Gussak I, Wright RS, Kopecky SL, Hammill SC. Exercise-Induced ST Segment Elevation in Q Wave Leads in Postinfarction Patients: Defining Its Meaning and Utility in Today's Practice. Cardiology 93 (4), 205-209, 2000 9 November 18, 2016 Curriculum Vitae Ihor Gussak, MD, PhD, FACC 49. Gussak I, Chaitman BR, Kopecky SL, Nerbonne JM. Rapid Ventricular Repolarization in Rodents: Electrocardiographic Manifestations, Molecular Mechanisms, and Clinical Insights. J Electrocardiol 33 (2):159-170, 2000 50. Gussak I, Wright RS, Stephen L. Kopecky SL. Should We Revise Our Diagnostic Methods for Q-wave Myocardial Infarction in the Presence of Right Bundle Branch Block? Editorial Review. Am Heart J 2000 Jul;140(1):10-11 51. Yokoyama Y, Chaitman BR, Hardison RM, Guo P, Krone R, Stocke K, Gussak I, Attubato MJ, Rautaharju PM, Sopko G, Detre KM. Association between new electrocardiographic abnormalities after coronary revascularization and five-year cardiac mortality in BARI randomized and registry patients. Am J Cardiol 2000 Aug 15;86(8):819-824 52. Gussak I, Antzelevitch C. Early Repolarization Syndrome: Clinical Characteristics and Possible Cellular and Ionic Mechanisms. J Electrocardiol 33 (4):299-309, 2000 53. Detre KM, Lombardero MS, Brooks MM, Hardison RM, Holubkov R, Sopko G, Frye RL, Chaitman BR. The effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. Bypass Angioplasty Revascularization Investigation Investigators. N Engl J Med 2000 Apr 6;342(14):989-97 54. Feit F, Brooks MM, Sopko G, Keller NM, Rosen A, Krone R, Berger PB, Shemin R, Attubato MJ, Williams DO, Frye R, Detre KM. Long-term clinical outcome in the Bypass Angioplasty Revascularization Investigation Registry: comparison with the randomized trial. BARI Investigators. Circulation 2000 Jun 20;101(24):2795-802 55. Brooks MM, Jones RH, Bach RG, Chaitman BR, Kern MJ, Orszulak TA, Follmann D, Sopko G, Blackstone EH, Califf RM. Predictors of mortality and mortality from cardiac causes in the bypass angioplasty revascularization investigation (BARI) randomized trial and registry. For the BARI Investigators. Circulation 2000 Jun 13;101(23):2682-9 56. Gussak I, Bjerregaard P, Antzelevitch C, Towbin J, Chaitman B.R. The Brugada Syndrome: Clinical, Electrophysiological and Genetic Aspects. Journal of the American College of Cardiology 33 (1): 5-15,1999 57. Bjerregaard P, Gussak I, Hurst JW. Naming of the waves in the ECG with a brief account of their genesis. Circulation 100:e148, 1999 58. Gussak I, Liebl N, Bjerregaard P, Nouri S, Zimmerman F, Chaitman B.R. Deceleration-Dependent Shortening of the QT Interval: a New Electrocardiographic Phenomenon? Clinical Cardiology 22:124-126, 1999 59. Gussak I, Zhou S, Rautaharju P, Bjerregaard P, Stocke K, Osada N, Yokoyama Y, Miller M, Islam S. Chaitman BR. Right bundle branch block as a cause of false-negative ECG diagnosis of inferior myocardial infarction. J Electrocardiol 32 (3):275-280, 1999 60. Gussak HM, Gellens ME, Gussak I, Bjerregaard P. Q-T interval dispersion and its arrhythmogenic potential in hemodialyzed patients: methodological aspects. Nephron 1999;82(3):278 61. Pepine CJ, Bourassa MG, Chaitman BR, Davies RF, Kerensky RA, Sharaf B, Knatterud GL, Forman SA, Pratt CM, Staples ED, Sopko G, Conti CR. Factors influencing clinical outcomes after revascularization in the asymptomatic cardiac ischemia pilot (ACIP). ACIP Study Group. J Card Surg 1999 Jan-Feb;14(1):1-8 62. Bjerregaard P, Gussak I, Antzelevitch C. The enigmatic ECG manifestation of the Brugada Syndrome. J Cardiovasc Electrophysiol 9: 109-111, 1998 63. Gussak I, Bjerregaard P. Proarrhythmic potential by K +-channel opening drugs. Heart 77: 487-488, 1997 64. Gussak I. Effect of 4-aminopyridine on ventricular repolarization in isolated rat and guinea pig hearts. In: Emerging Therapeutic Targets, eds. R. Anand, P. Smith, P. Warne. v. 1:133-137. London: Ashley Publications LTD, 1997 65. Gussak I, Bjerregaard P, Greenwalt T, Chaitman BR. Electrophysiological peculiarities of the ECG J wave: from hypothermia to Brugada syndrome. pp. 261-264. In: Electrocardiology 96: From the Cell to the Body Surface (ed. J. Liebman). World Scientific Co.Pte. Ltd., Singapore, 1997 10 November 18, 2016 Curriculum Vitae Ihor Gussak, MD, PhD, FACC 66. The Bypass Angioplasty Revascularization Investigation (BARI). Influence of Diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease. Circulation 96:1761-1769, 1997 67. The Writing Group for the Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Five year clinical and functional outcome comparing bypass surgery and angioplasty in patients with multivessel coronary disease. JAMA 277:715-721, 1997 68. BARI Investigators. Myocardial infarction and cardiac mortality in bypass angioplasty revascularization investigation (BARI) randomized trial. Circulation 96:2162-2170, 1997 69. Chaitman B, Jacobs A, Ohman J, Krone R, Mullany C, Sopko G, Gussak I, Sutton-Tyrrell K, Rosen A. Periprocedure Myocardial Infarction Rates in the Bypass Angioplasty Revascularization (BARI). Journal of the American College of Cardiology Supplement, February 1996, 1010-115:361A 70. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. N Engl J Med 336:92-99, 1997 71. Zhou SH, Chaitman BR, Rautaharju PM, Gussak I, Stocke KS. Gender differences in ECG Q wave serial changes. pp. 541-544. In: Electrocardiology 96: From the Cell to the Body Surface (ed. J. Liebman). World Scientific Co. Pte. Ltd., Singapore, 1997 72. Gussak I. The significance of the electrocardiographic J wave: from hypothermia to Brugada Syndrome. Medicine around the World 2 (4): 237-239, 1997 73. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 335:217-225, 1996 74. Goldberg AD, Becker LC, Bonsall R, Cohen JD, Ketterer MW, Kaufman PG, Krantz DS, Light KC, McMahon RP, Noreuil T, Pepine CJ, Raczynski J, Stone PH, Strother D, Taylor H, Sheps DS. Ischemic, hemodynamic, and neurohormonal responses to mental and exercise stress. Experience from the Psychophysiological Investigations of Myocardial Ischemia Study (PIMI). Circulation 1996 Nov 15;94(10):2402-9 75. Chaitman BR, Zhou SH, Tamesis B, Rosen A, Egan T, Zumbehl KM, Stocke K, Takase B., Gussak I, Rautaharju PM. Methodology of serial ECG classification Using an adaptation of the NOVACODE for Q wave myocardial infarction in the Bypass Angioplasty Revascularization Investigation. J Electrocardiol 29:265-277, 1996 76. Gussak I, Bjerregaard P, Egan T, Chaitman BR. ECG phenomenon called the J wave. History, pathophysiology, and clinical significance. J Electrocardiol 28: 49-58, 1995 77. Hirulog Angioplasty Study Investigators. Treatment with Bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. N Engl J Med 333:764-769, 1995 78. Bjerregaard P, Gussak I, Kotar SL, Gessler JE, Janosik D. Recurrent syncope in a patient with prominent J wave. Am Heart J 126: 1427-1430, 1994 79. Gussak I, Altraja E, Teesalu R. Myocardial vulnerability diagnosis in ischemia. Eesti Tervishoid 5: 334-345, 1986 80. Gussak I. Cardiac electrostimulation in tachycardias and tachyarrhythmias. Eesti Tervishoid 5: 245-249, 1986 81. Gussak I. The study of cardiac arrhythmias utilizing esophageal electrocardiostimulation. Eesti Tervishoid 4: 253-256, 1984 Abstracts (will be provided upon request) 11 November 18, 2016 Curriculum Vitae Ihor Gussak, MD, PhD, FACC PATENTS 1. SYSTEM AND METHODS FOR SERIAL ANALYSIS OF ELECTROCARDIOGRAMS (Patent application number: 20110112414; Published 05-12-2011) 2. SYSTEM FOR AUTOMATED EKG ANALYSIS (Patent application number: 20110112414; Published 05-12-2011) 3. SYSTEM AND METHOD FOR AUTOMATED EKG ANALYSIS (Patent application number: 20110112415; Published 05-12-2011) 4. SYSTEM AND METHODS FOR SERIAL ANALYSIS OF ELECTROCARDIOGRAMS (Patent application number: 20130096447; 04-18-13) REFERENCES (will be provided upon request) 12